Overexpression of AURKA is reported in numerous tumors including melanoma, leukemia, pancreatic, ovarian, gastrointestinal, esophageal kidney, colon, breast and prostate cancer (PCa) [3]. Here, AURKA is linked to prostate carcinoma.